๐ฐ Scott Kellen News
Page 2 - Scott Kellen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Scott Kellen. Real-time updates on events, politics, business and more.
July 17, 2021
MINNEAPOLIS--(BUSINESS WIRE)--Jul 15, 2021-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the election of two industry veterans to the Companyรขยยs Board of Directors. Amy Burroughs, President and CEO of Cleave Therapeutics, brings over 20 years of experience in business and commercial development, strategy and leadership in the pharmaceutical indust...
May 5, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation. DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results May 5, 2021 GMT MINNEAPOLIS--(BUSINESS WIRE)--May 5, 2021-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update and financial results for the quarter...
March 10, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation. DiaMedica Therapeutics Hosting Key Opinion Leader Webinar on DM199 for Treatment of Acute Ischemic Stroke March 9, 2021 GMT MINNEAPOLIS--(BUSINESS WIRE)--Mar 9, 2021-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical stage biopharmaceutical company developing novel treatments for neurological and kidney diseases, today announced that it will host a key opinion leader (KOL) webinar on DM199, the C...